Search Results - "Schizophrenia"

Needs for care of residents with schizophrenia spectrum disorders and association with daily activities and mood monitored with experience sampling method: the DIAPASON study by Alessandra Martinelli, Miriam D'Addazio, Manuel Zamparini, Graham Thornicroft, Gabriele Torino, Cristina Zarbo, Matteo Rocchetti, Fabrizio Starace, Letizia Casiraghi, Mirella Ruggeri, Giovanni de Girolamo, the DiAPASon Collaborators

Connect to this object online.

No relationship between 2',3'-cyclic nucleotide 3'-phosphodiesterase and schizophrenia in the Chinese Han population: an expression study and meta-analysis by Zhang Zhao, Wei Zhiyun, Zhang Jing, Tang Wei, Che Ronglin, Huang Ke, Zhao Xinzhi, Gao Jianjun, Zhou Guoquan, Huang Peirong, He Lin, Shi Yongyong

Connect to this object online.

Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort by Nathan Vidal, Nathan Vidal, Paul Roux, Paul Roux, Mathieu Urbach, Mathieu Urbach, Cristobal Belmonte, Cristobal Belmonte, Laurent Boyer, Laurent Boyer, Delphine Capdevielle, Delphine Capdevielle, Delphine Capdevielle, Julie Clauss-Kobayashi, Julie Clauss-Kobayashi, Thierry D'Amato, Thierry D'Amato, Romane Dassing, Romane Dassing, Caroline Dubertret, Caroline Dubertret, Julien Dubreucq, Julien Dubreucq, Guillaume Fond, Guillaume Fond, Roxana-Mihaela Honciuc, Roxana-Mihaela Honciuc, Sylvain Leignier, Sylvain Leignier, Pierre-Michel Llorca, Pierre-Michel Llorca, Jasmina Mallet, Jasmina Mallet, David Misdrahi, David Misdrahi, Baptiste Pignon, Baptiste Pignon, Romain Rey, Romain Rey, Franck Schürhoff, Franck Schürhoff, Arnaud Tessier, Arnaud Tessier, the FACE-SZ (FondaMental Academic Centers of Expertise-Schizophrenia), Christine Passerieux, Christine Passerieux, Eric Brunet-Gouet, Eric Brunet-Gouet, B. Aouizerate, V. Barteau, S. Bensalem, F. Berna, O. Blanc, E. Bourguignon, L. Boyer, D. CapdevielleI. Chéreau, G. Chesnoy-Servanin, T. D'Amato, A. Deloge, H. Denizot, JM. Dorey, C. Dubertret, J. Dubreucq, S. Esselin, C. Faget, C. Fluttaz, G. Fond, F. Gabayet, O. Godin, E. Haffen, RM. Honciuc, M. Jarroir, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, PM Llorca, J. Mallet, E. Metairie, D. Misdrahi, C. Passerieux, J. Petrucci, P. Peri, B. Pignon, S. Pires, C. Portalier, R. Rey, C. Roman, F. Schürhoff, K. Souryis, A. Szöke, M. Urbach, F. Vaillant, A, Vehier, P. Vidailhet, E. Vilà, G. Wahiche, H. Yazbek, A. Zinetti-Bertschy

Connect to this object online.

Assessment of electroencephalography modification by antipsychotic drugs in patients with schizophrenia spectrum disorders using frontier orbital theory: A preliminary study by Takashi Ozaki, Koichiro Mikami, Atsuhito Toyomaki, Naoki Hashimoto, Yoichi M. Ito, Ichiro Kusumi

Connect to this object online.

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia by Chia-Hao Ma, Hung-Yu Chan, Ming H. Hsieh, Chen-Chung Liu, Chih-Min Liu, Hai-Gwo Hwu, Ching-Hua Kuo, Wei J. Chen, Tzung-Jeng Hwang

Connect to this object online.

ATA homozigosity in the <it>IL-10 </it>gene promoter is a risk factor for schizophrenia in Spanish females: a case control study by Fernandez-Piqueras Jose, Baca-García Enrique, Fernandez-Navarro Pablo, Lopez-Rodriguez Rosario, Dorado Pedro, Lopez-Castroman Jorge, Riveiro-Alvarez Rosa, Almoguera Berta, Dal-Ré Rafael, Abad-Santos Francisco, LLerena Adrián, Ayuso Carmen

Connect to this object online.

The relationship between sleep disturbance and aggressive behaviour among community-dwelling schizophrenia patients: a moderated mesomeric effect model by Zixiang Ye, Dongmei Wu, Yuchuan Yue, Tao Li, Li Sun, Pei Yu, Yuhao Tong, Li Xiao

Connect to this object online.

Discrepancies between Self- and Clinical Staff Members' Perception of Cognitive Functioning among Patients with Schizophrenia Undergoing Long-Term Hospitalization by Fumiko Kaneko, Hitoshi Okamura

Connect to this object online.

Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization by Wang Chen-Pin, Zeber John E, Copeland Laurel A, Parchman Michael L, Lawrence Valerie A, Valenstein Marcia, Miller Alexander L

Connect to this object online.

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia by Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina, Vasilis P. Bozikas, Halise Devrimci-Ozguven, Sung-Wan Kim, Paul Bergmans, Irina Usankova, Katalin Pungor

Connect to this object online.

Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta‐analysis of phase 3 trials in Japan by Taro Kishi, Tadashi Nosaka, Kenji Sakuma, Makoto Okuya, Nakao Iwata

Connect to this object online.

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study by Shinsuke Hidese, Fuyuko Yoshida, Ikki Ishida, Junko Matsuo, Kotaro Hattori, Hiroshi Kunugi

Connect to this object online.

Relationship between quality of life of men who's wives suffer from the paranoid schizophrenia, and features its clinical-psychopathological manifestations by Maiya Driuchenko

Connect to this object online.

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia by Jiahong Liu, Meihong Xiu, Haixia Liu, Jun Wang, Xirong Li

Connect to this object online.

Comprehensive assessment of exposure to clozapine in association with side effects among patients with treatment-resistant schizophrenia: a population pharmacokinetic study by Nobuyuki Nomura, Kohei Kitagawa, Ryuhei So, Fuminari Misawa, Masafumi Kodama, Hiroyoshi Takeuchi, Robert Bies, Thomas Straubinger, Christopher Banker, Yuya Mizuno, Masaru Mimura, Hiroyuki Uchida

Connect to this object online.

Early-Onset Schizophrenia With Predominantly Negative Symptoms: A Case Study of a Drug-Naive Female Patient Treated With Cariprazine by Maria Judit Molnar, Idris János Jimoh, Helga Zeke, Ágnes Palásti, Marianna Fedor

Connect to this object online.

<b>New drugs for the treatment of agitation in schizophrenia: a systematic review and meta-analysis of inhaled loxapine and infused sodium nitroprusside by Fernanda Stumpf Tonin, Thais Piazza, Helena Hiemisch Lobo Borba, Astrid Wiens, Roberto Pontarolo

Connect to this object online.

The occurrence and nature of early signs of schizophrenia and psychotic mood disorders among former child and adolescent psychiatric patients followed into adulthood by Rydelius Per-Anders, Engqvist Ulf

Connect to this object online.

Salivary Flow Alteration in Patients Undergoing Treatment for Schizophrenia: Disease-Drug-Target Gene/Protein Association Study for Side-effects by Anusa Arunachalam Mohandoss, Rooban Thavarajah

Connect to this object online.

Pyr1-Mediated Pharmacological Inhibition of LIM Kinase Restores Synaptic Plasticity and Normal Behavior in a Mouse Model of Schizophrenia by Sylvie Gory-Fauré, Sylvie Gory-Fauré, Rebecca Powell, Rebecca Powell, Julie Jonckheere, Julie Jonckheere, Fabien Lanté, Fabien Lanté, Eric Denarier, Eric Denarier, Eric Denarier, Leticia Peris, Leticia Peris, Chi Hung Nguyen, Alain Buisson, Alain Buisson, Laurence Lafanechère, Laurence Lafanechère, Annie Andrieux, Annie Andrieux, Annie Andrieux

Connect to this object online.